Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin and ESWT in Cerebral Palsy
NCT05627921Unknown
- Sponsor
- Marmara University
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of botulinum toxin type A in cerebral palsy (CP) and spasticity (2 arms), sponsored by Marmara University. Primary endpoint: Modified Tardieu Scale at 6 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)spasticity
Beyond the preview
Go deeper on NCT05627921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05627921.